title: Clarifications about add-on payments for fidaxomicin.
authors.forename: Hemal
authors.initials: H
authors.lastname: Shah
authors.forename: Anna M
authors.initials: AM
authors.lastname: Tallman
authors.forename: Shelley
authors.initials: S
authors.lastname: Capurso
mesh_terms: D000617:Aminoglycosides / Q000191:economics* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D014487:Centers for Medicare and Medicaid Services, U.S. / Q000191:economics* / Q000592:standards; D000077732:Fidaxomicin; D006801:Humans; D012051:Reimbursement Mechanisms / Q000191:economics* / Q000592:standards; D014481:United States
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000077732:Fidaxomicin